FLT3 expression initiates in fully multipotent mouse hematopoietic progenitor cells

Area of Science:

• Hematopoiesis
• Cell Biology
• Molecular Biology

Background:

• FLT3 (Fms-like tyrosine kinase 3) is a key receptor tyrosine kinase involved in hematopoietic stem cell (HSC) development.
• FLT3 expression patterns differ between human and mouse hematopoiesis, impacting the utility of mouse models.

Purpose of the Study:

• To investigate the precise timing and cell-type specificity of Flt3 expression during mouse hematopoiesis.
• To clarify the relevance of FLT3 expression patterns for mouse models utilizing Flt3 mutations.

Main Methods:

• Utilized Flt3-Cre fate mapping to trace Flt3 expression in progenitor cells.
• Analyzed cell-surface FLT3 protein expression in various hematopoietic progenitor populations.

Main Results:

• FLT3 expression is initiated in fully multipotent progenitors in mice.
• Lymphoid-primed progenitors show high FLT3 expression, while HSCs and megakaryocyte-erythroid (MkE) progenitors lack detectable FLT3.
• Flt3-Cre fate mapping revealed FLT3 expression in lymphoid, granulocyte-monocyte, and Mk- and E-restricted progenitors.

Conclusions:

• Mouse Flt3 expression begins earlier than previously thought, in multipotent progenitors.
• This early expression pattern in mice contrasts with human hematopoiesis and has implications for Flt3 mutation modeling.